Chicago Equity Partners’s AngioDynamics ANGO Stock Holding History

Chicago Equity Partners’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-34,500	Closed	-$750K	–	806
2018 Q3	$750K	Sell	34,500 -32,035	-48%	-$712K	0.02%	587
2018 Q2	$1.48M	Buy	66,535 +25,710	+63%	+$525K	0.05%	441
2018 Q1	$704K	Buy	+40,825	New	+$681K	0.02%	553
2017 Q3	–	Sell	-49,090	Closed	-$796K	–	740
2017 Q2	$796K	Buy	49,090 +22,930	+88%	+$363K	0.02%	549
2017 Q1	$454K	Buy	+26,160	New	+$437K	0.01%	608

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Chicago Equity Partners's ANGO Position: Q4 2018 in Review

Chicago Equity Partners sold out of AngioDynamics (ANGO) in Q4 2018, closing a stake of 34,500 shares — an estimated $750K sold.

Chicago Equity Partners first reported a position in ANGO in Q1 2017 and held it in 5 quarters. The position peaked at $1.48M in Q2 2018. 174 funds tracked by Wall St. Rank hold ANGO as of Q4 2018.

Chicago Equity Partners reported no remaining AngioDynamics position as of Q4 2018 after selling out during the quarter.
Chicago Equity Partners sold 34,500 AngioDynamics shares in Q4 2018, an estimated $750K.
Chicago Equity Partners first reported a position in AngioDynamics in Q1 2017 and held it in 5 quarters.
Chicago Equity Partners's AngioDynamics position peaked at $1.48M in Q2 2018.
174 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2018.

Based on Chicago Equity Partners's 13F filing for Q4 2018, filed 5 Feb 2019.